Baljeet Uppal, MD
Vascular Surgery · Sun City, AZNPI 1689898165
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $131,400 of the $166,372 with a category attached, or 79.0%. Endologix LLC accounts for 65.6% of it on its own, with 33 other manufacturers making up the rest. Reporting peaked in 2020 at $36,671 and has fallen 61.7% since, to $14,042 in 2025. Among vascular surgery clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 658 payments — averaging $252.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endologix LLC$109K
- Bard Peripheral Vascular, Inc.$42K
- Angiodynamics, Inc.$3K
- Penumbra, Inc.$2K
- Medtronic$1K
- Cardiovascular Systems Inc.$1K
- plus $8K from 28 others
What the payments were for
- Consulting fees$131,40079%
- Travel & lodging$2,6222%
- Food & beverage$30,02718%
- Education$460%
- Other$2,2781%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Endologix LLC | 259 | $109,209 |
| Bard Peripheral Vascular, Inc. | 74 | $42,174 |
| Angiodynamics, Inc. | 10 | $2,560 |
| Penumbra, Inc. | 4 | $1,710 |
| Medtronic(2 entities) | 45 | $1,399 |
| Cardiovascular Systems Inc. | 47 | $1,245 |
| Boston Scientific | 28 | $1,142 |
| W. L. Gore & Associates, Inc. | 38 | $1,128 |
| Inari Medical, Inc. | 10 | $886 |
| Abbott | 33 | $847 |
| Silk Road Medical, Inc. | 8 | $757 |
| Shockwave Medical, Inc | 3 | $654 |
| Surmodics, Inc. | 12 | $561 |
| Bolton Medical Inc | 15 | $325 |
| Reflow Medical Inc | 6 | $315 |
| Lemaitre Vascular, Inc. | 5 | $218 |
| Philips North America LLC | 14 | $165 |
| Cardinal Health 200 LLC | 1 | $145 |
| Biotronik Inc. | 1 | $119 |
| Johnson & Johnson | 5 | $113 |
| Terumo Medical Corporation | 4 | $107 |
| Cook Medical LLC | 8 | $91 |
| Smith+Nephew | 5 | $91 |
| Inspiremd Ltd | 1 | $86 |
| Cagent Vascular Inc | 3 | $62 |
| Biocompatibles, Inc. | 3 | $49 |
| Cardiva Medical, Inc. | 3 | $46 |
| Cordis US CORP. | 2 | $41 |
| Tactile Systems Technology Inc | 2 | $36 |
| Asahi Intecc USA, Inc. | 1 | $21 |
| Artivion, Inc. | 5 | $21 |
| Imperative Care, Inc | 1 | $19 |
| Stryker | 1 | $16 |
| Catheter Precision, Inc. FKA Ra Medical Systems, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AFX2 Bifurcated Endograft System$41,913
- Alto Abdominal Stent Graft System$25,618
- AFX$22,993
- Ovation$20,734
- Auryon Laser System 100-120 Vac$2,411
- Indigo$1,552
- ENDOCROSS Device$1,157
- Torus Stent Graft System$1,157
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$654
- FLOWTRIEVER CATHETER, S$590
- CT THROMBECTOMY SYSTEM KIT$590
- ENROUTE .014 Guidewire$527
- ENHANCE Transcarotid Peripheral Access Kit$527
- ENROUTE Transcarotid Stent$527
- ENROUTE Transcarotid Neuroprotection System$527
- Diamondback Peripheral$324
- Pounce Thrombectomy System$297
- Pounce Venous Thrombectomy System$297
- RotarexS 6 F x 135 cm$275
- Endurant$272
How this compares
$166,372 in reported general payments places this provider in the 95th percentile of 105 vascular surgery providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 13 | $11,150 |
| ClopidogrelClopidogrel Bisulfate | 457 | $5,695 |
| Prednisone | 12 | $35 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $113 | $11,15013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 105 vascular surgery providers in Arizona.
Other vascular surgery in Sun City
- Isaiah BrownSun City$22K
- Venkatesh RamaiahScottsdale$452K
- Jeromy BrinkPhoenix$392K
- Luis LeonPhoenix$185K
- Hammad AmerMesa$169K
- Scott BermanTuscon$150K
- Martin ZomayaPhoenix$139K
- Joshua BaldermanTucson$135K
- John PacanowskiTucson$85K
- Joseph VijungcoChandler$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.